There is now extensive evidence to indicate that components of the cyclic adenosine monophosphate (cAMP) 
myometrium are differentially expressed during gestation and parturition [12] . This was in contrast to expression of RI␣, C␣ and C␤ which remained uniform whereas RI␤/RII␤ were undetected [12] . Our data indicated that expression levels of RII␣ mRNA and protein were substantially increased and decreased during pregnancy and labour, respectively, which was mirrored by similar changes in particulate type II PKA activity. [13] (see Fig. 1A ). Foss et al. [13] [14] . However there is a growing body of evidence showing that such genes can indeed be a target of tissue/cell type specific control [15, 16] [17] [18] [19] . [20] . Furthermore, the presence of a high number of CpG methylation sites in the promoter region of the RII␣ gene also points to a potential role for promoter DNA methylation as an important regulatory factor in controlling expression of the gene.
Thus dynamic regulation of RII␣ expression is an important means of influencing smooth muscle contractile function. Consequently the purpose of the present study was to identify potential mechanisms by which expression of the RII␣ (PRKAR2A) gene is regulated in human myometrial smooth muscle cells. Although there is a paucity of information of how the RII␣ gene is regulated in any tissue or cell type, the promoter region of the RII␣ gene has been fully characterized

indicated that this region is GC rich and TATA-less with a CpG island present in the proximal region of the promoter (http://linux1.softberry.com/berry.phtml) (Fig. 1A). Characteristically genes with similar features within their promoters are classified as house-keeping genes, as expression levels do not vary among different cell types
. The proximal promoter region -1206 bp upstream from the ϩ1 transcriptional start site of the RII␣ gene indicates the presence of several potential binding sites for AP1, AP2, NF1, NF-B as well as three SpI-III GC boxes representing canonical binding sites for the specificity protein family (Sp1-4). In many instances Sp1-4 proteins have been observed to recruit HDACs to the promoter region of genes which contain GC elements to silence their expression
We have also shown this to be the case in human myometrial cells where expression of the hCG/LH receptor gene is repressed by recruitment of HDACs 1/2 to the two SpI-II (GC) binding domains within the proximal promoter
In the present study, we assess the possible role of SpI-III GC binding domains and HDACs 1/2 in epigenetically regulating RII␣ gene and protein expression in human uterine smooth muscle cells.
Materials and methods
Preparation of primary myometrial cell cultures
Primary cell cultures were established and cultured from non-pregnant myometrial tissue samples as described previously [21, 22] 
. Samples were taken from the uteruses removed from women undergoing hysterectomy from benign gynaecological conditions (38 to 58 years old). Written consent was obtained from all women, and ethical approval was granted by the North Tyneside Health Authority Ethics Committee.
Western blotting
Western blotting was carried out as described previously [20, 21] . Essentially total protein (10 g 
DNA affinity precipitation assays (DAPAs)
DAPAs were performed as described in (16) 
Co-immunoprecipitation (co-IP)
Preparation of RII␣ promoter luciferase reporter constructs
Four RII␣ promoter luciferase reporter constructs were prepared using similar cloning methods as described in [20] . The 
Myometrial contractility studies
Longitudinal myometrial strips (measuring approximately 2 ϫ 2 ϫ 10 mm) were mounted for isometric recording under 2 mN of tension in organ baths as previously described [24] . (Fig. 1B) . Specificity of DNA protein binding proteins was determined by co-incubation with specific and non-specific competitors. Here incubation of 50ϫ excess of specific non-labelled oligonucleotides for the respective SpI element showed reductions in the detected signal for both Sp1 and Sp3 whereas the non-specific competitor Oct1 consensus element had no effect (Fig. 1C) , similar results were obtained for the SpII and III elements (data not shown). HDAC1 and 2 were also specifically pulled down by all three SpI-III (GC) promoter elements in nuclear fractions, however a weak signal for HDAC2 was also observed in the cytoplasmic fraction (Fig. 1B) . DAPAs were also [25, 26] . This appeared to be the case in myometrial cells where 6 hrs treatment with 2 M Mithramycin A significantly decreased basal RII␣ protein levels ( Fig. 2A) [19] . (Fig. 3) , as per the hCG/LH receptor promoter [19] , whereas in contrast Sp3 only coprecipitated with HDAC2 but not with HDAC1 (Fig. 3) . These results were confirmed by a second co-IP with HDAC1 and 2 with subsequent Western blotting with the anti-Sp3 Antibody (data not shown). In these assays RbAp48 was observed to be precipitated with both HDACs1/2 (Fig. 3) . (Fig. 4B) . All pull-downs were specific as monitored by Rabbit/Mouse IgG controls compared to DNA inputs (Fig. 4C) . (Fig. 5A) . However the presence of the single SpI element was still enough to increase luciferase activity compared to the empty vector control (Fig. 5A) (Fig. 5C) . However methylation did not attenuate the effect of TSA treatment on transcriptional activity of this RII␣ construct, as the luciferase signal was increased to the same extent in both the methylated and mock treated constructs (Fig. 5C ).
Results
Assessment of transcriptional regulator recruitment to the SpI-III (GC) binding elements within the RII␣ promoter region in human myometrial cells
DAPA analysis indicated that both Sp1 and Sp3 specifically bound the three SpI-III (GC) boxes within the proximal promoter region of the RII␣ gene (Fig. 1B). Note that Sp3 has several well documented isoforms which are detected with the Sp3 antibody used here in DAPAs and Western blotting. No binding was observed for either Sp2 or Sp4 (data not shown). In each instance Sp1 and Sp3 binding was only observed in nuclear fractions whereas no signal was observed after incubation of the biotinylated oligonucleotides with cytoplasmic fractions
Co-immunoprecipitations assays were therefore employed to determine if similar events occurred on the RII␣ promoter in human myometrial cells. In this instance interactions between Sp1 and HDACs1/2 was detected
Assessment of in situ recruitment of transcriptional regulators to the RII␣ promoter in human myometrial cells
ChIP assays were performed to confirm that the data accrued via in vitro DAPA analyses also occurred in vivo. In this instance ChIP analysis of all three RII␣ SpI-III (GC) binding domains indicated that Sp1, Sp3, HDAC1/2 and RbAp48 were all recruited to these cis-elements whereas mSin3A appeared not to be. Moreover, TSA treatment for 6 hrs increased the binding of both Sp3 and HDAC2 approximately 2-fold to the three SpI-III (GC) elements (Fig. 4A); whereas no change in binding was observed for Sp1, RbAp48 and HDAC1. Additionally a 3-4-fold increase in binding of acetylated Histone 3 (aH3) after 6 hrs treatment with TSA (330 nM) was also seen (Fig. 4B) which correlated with an increase in acetylated Histone 3 (aH3) as monitored by Western analysis (data not shown). Because real time RT-PCR indicated that RII␣ mRNA levels increased after 6 hrs treatment with TSA (see below) a specific Polymerase IIa (PolIIa) antibody was used in ChIP to ascertain whether increased mRNA expression was associated with increased PolIIa binding to these RII␣ promoter regions. Indeed for all three binding sites a 3-4-fold increase in binding of PolIIa was observed for cells treated with TSA whereas levels of binding did not significantly change for cells treated with 5-AzaC (100 M)
Regulation of transcriptional activation of RII␣ in human myometrial cells by acetylation or methylation
Full and truncated forms of the RII␣ promoter region, detailed in Fig. 4, were used in transient transfection of human primary myometrial cell cultures to investigate the involvement of the three SpI-III (GC) consensus elements in transcriptional activity of the RII␣ gene. Initially, basal luciferase activity was measured for the full length promoter and the three constructs with sequential deletion of the SpI-III (GC) elements. The highest expression as monitored by luciferase activity was observed for the promoter construct containing all three SpI-III (GC) elements (Fig. 4A) but lacking the distal part of the promoter, indicating that all three SpI-III (GC) elements are necessary for maximal expression of the RII␣ gene. Because transfection of the full-length construct resulted in lower luciferase activities than that of the construct containing the three SpI-III (GC) elements this may indicate the presence of inhibitory elements up-stream of these GC binding domains.
Regulation of RII␣ protein levels in human myometrial cells following TSA or 5-AzaC treatment
To define whether inhibition of HDACs1/2 and DNA methylation status could affect RII␣ protein expression levels in vivo in human myometrial cells; total protein extracts were prepared from myometrial cell cultures treated with TSA and 5-AzaC and subjected to Western blotting with the RII␣ antibody. To determine the optimal treatment times, cells were incubated with TSA (330 nM) and 5-AzaC (100 M) for 6, 24 and 48 hrs. TSA increased RII␣ protein levels after 6 hrs which then slightly declined after 24 and 48 hrs but remained higher than control levels (Fig. 5A) . 5-AzaC also increased RII␣ protein levels after 6 hrs treatment, which was maintained up to 24 and 48 hrs (Fig. 6A) . On the basis of these initial results 6 hrs treatment with TSA and 5-AzaC were chosen for further protein and mRNA analysis (as well as the above ChIP analyses). Note that a 6 hrs treatment of GH3 cells with TSA has been shown to significantly increase GH mRNA [28] . Similarly an 80% decrease in DNA methyltransferase activity has been observed in cell lines treated for 4 hrs with the demethylating agent 5-AzaC [29] . Employing this incubation time significant increases in RII␣ protein levels were observed for both TSA and 5-AzaC treatment (Fig. 6B) . 
TSA, but not 5-AzaC, increases RII␣ mRNA levels in human myometrial cells
TSA inhibits myometrial contractions
Because TSA treatment increases RII␣ protein expression in cell cultures we investigated whether this also occurred in myometrial strips and defined the effect on myometrial contractility. Here, TSA caused a significant decrease in oxytocin-induced contractions (Fig. 7A-D) similar to that described in [30] and this was associated with an increase in RII␣ protein expression and an increase in Histone 3 acetylation at 1 and 6 hrs (Fig. 7E ). 
Discussion
